Hologic posted strong revenues for its fiscal third quarter, which it attributed in part to recovery from the COVID-19 pandemic.
For the period (end-June 26), Hologic reported revenue of $1.168 billion, up 42% from $822.9 million for the same quarter last year. It posted third-quarter sales for its Diagnostics division of $665.5 million, up 24% compared with 2020's $524.4 million. Its Breast and Skeletal Health segment posted sales of $349 million, up 55.8% compared with 2020's $224 million.
Finally, the company's net income for the quarter was $268.4 million, an increase of 94.6% compared with the third quarter of 2020.
